Publication | Closed Access

A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-d-mannuronic acid in rheumatoid arthritis patients

Rheumatoid DisorderRheumatologyAnti-inflammatoryAutoimmune DiseaseRheumatic DiseasesPharmacologyClinical TrialsInflammatory Rheumatic DiseaseRheumatoid Arthritis PatientsMedicinePhase I/iiRheumatoid Arthritis